Sunday, December 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Goldman Sachs Analyst Maintains Buy Rating for Nutrien with Lowered Price Target

Elaine Mendonca by Elaine Mendonca
February 1, 2024
in Breaking News
0
Finance_Budgeting (1)
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

On February 1, 2024, Adam Samuelson, an analyst at Goldman Sachs, reaffirmed his positive sentiment towards Nutrien (NTR) by maintaining a Buy rating. However, he did make an adjustment to the price target, lowering it from $88 to $78. This adjustment aligns with the median target of $75.00 suggested by a group of 23 analysts.

Although the price target has decreased, the Buy rating still signifies an optimistic outlook for Nutrien’s stock. It is crucial for investors to take into account the diverse range of analyst recommendations and price targets in order to make well-informed investment decisions.

NTR (Nutrien Ltd.) Stock Performance Shows Positive Signs with 2.17% Rise: Potential Undervaluation or Challenges?

On February 1, 2024, the stock performance of NTR (Nutrien Ltd.) showed some positive signs with a 2.17% rise in price since the market last closed. NTR opened at $50.36, which was $0.49 higher than its previous close, indicating some positive sentiment surrounding the stock at the opening of the market. The stock was trading near the bottom of its 52-week range, suggesting potential undervaluation or challenges. Investors and analysts would have closely monitored NTR’s stock throughout the day to assess its future performance.

NTR Stock Performance on February 1, 2024: Mixed Results with Strong Revenue Growth but Decline in Net Income and EPS

NTR Stock Performance on February 1, 2024:

Total Revenue:
– NTR reported a total revenue of $37.88 billion over the past year, a 36.71% increase compared to the previous year.
– However, when compared to the previous quarter’s figure of $5.63 billion, there was a significant decline of 51.68%.

Net Income:
– NTR reported a net income of $7.66 billion over the past year, a substantial increase of 142.94%.
– The net income for the most recent quarter, Q3, stood at $75.00 million, indicating a decline of 82.95% compared to the previous quarter.

Earnings per Share:
– NTR’s EPS over the past year was reported at $14.18, a significant increase of 157.01%.
– The EPS for the most recent quarter, Q3, was reported at $0.15, representing a decline of 82.92% compared to the previous quarter.

Overall, NTR’s stock performance on February 1, 2024, showcased a mixed picture. While the company experienced substantial growth in total revenue, net income, and EPS over the past year, the most recent quarter’s figures indicated a decline across these key financial metrics. Investors should carefully analyze the reasons behind the decline before making investment decisions.

Tags: NTR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Real Estate Investment Markets and money

Analyst Maintains Positive Outlook on DR Horton with Revised Price Target

Corbus Pharmaceuticals Raises Funds for Clinical Development and Faces Market Fluctuations

Diana Shipping Inc Secures Major Time Charter Contract with Nippon Yusen Kabushiki Kaisha

Recommended

JD.com Stock

Pivotal Week Ahead for JD.com as Major European Acquisition and EV Launch Converge

2 months ago
Snowflake Stock

Snowflake Faces Investor Confidence Test After Executive’s Rogue Forecast

2 months ago
Fiserv Stock

Fiserv’s Strategic Expansion Meets Legal Scrutiny

3 months ago
Does_Walmart_Take_Google_Pay

Does Walmart Take Google Pay? Exploring Walmart’s Exclusive Payment Solution

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

Strategy Inc. Faces a Critical Index Classification Decision

DeFi Technologies Broadens Global Reach with New Listings and Products

Barrick Gold Secures Key Resolution in Mali, Paving Way for Mine Restart

Analyst Upgrade Sends Red Cat Shares Soaring

A Billion-Dollar Vote of Confidence for Standard Lithium

Trending

Tesla Stock
Automotive & E-Mobility

Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push

by Dieter Jaworski
December 21, 2025
0

Tesla shares are trading near their 52-week high as the company approaches a pivotal week, fueled by...

Wolfspeed Stock

Wolfspeed Secures Financial and Strategic Milestones

December 21, 2025
Textron Stock

Textron Stock Approaches Annual Peak Amid Strategic Wins

December 21, 2025
Intellia Therapeutics Stock

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

December 21, 2025
Strategy Stock

Strategy Inc. Faces a Critical Index Classification Decision

December 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push
  • Wolfspeed Secures Financial and Strategic Milestones
  • Textron Stock Approaches Annual Peak Amid Strategic Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com